News

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...
U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...
The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.
Mature overall survival results of the INAVO120 trial were presented in a press conference for the American Society of ...
The US Food and Drug Administration has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines.
Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...
An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...
CHICAGO -- Adding the PI3K-pathway inhibitor inavolisib (Itovebi) to palbociclib (Ibrance) and fulvestrant significantly ...
Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...
After a devastating diagnosis, Simone I. Smith and husband LL COOL J sought answers and a new mission to help others ...
We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at ...